# Edwards Lifesciences (EW) — Analyst Forecast

EW · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/ew/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 24 | 7 | 0 | 31 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $95.00 | $104.57 | $110.00 | 7 |

Last price $88.10 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 7, 2026 | Barclays | Initiated Coverage | Overweight | $110.00 |
| Sep 11, 2026 | BTIG | Maintained | Buy | $110.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Neutral → Buy | $110.00 |
| Jul 24, 2026 | Piper Sandler | Maintained | Overweight | $101.00 |
| Jul 24, 2026 | JP Morgan | Maintained | Overweight | $105.00 |
| Jul 24, 2026 | Leerink Partners | Upgraded | Market Perform → Outperform | $101.00 |
| Jul 16, 2026 | Truist Securities | Maintained | Hold | $95.00 |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | $105.00 |
| Jul 13, 2026 | RBC Capital | Maintained | Outperform | $110.00 |
| Jul 8, 2026 | Citigroup | Maintained | Buy | $110.00 |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | $100.00 |
| Jun 30, 2026 | BTIG | Maintained | Buy | $110.00 |
| Jun 16, 2026 | RBC Capital | Maintained | Outperform | $100.00 |
| Jun 2, 2026 | TD Cowen | Maintained | Buy | $104.00 |
| Apr 27, 2026 | Barclays | Maintained | Overweight | $110.00 |
| Apr 24, 2026 | Baird | Maintained | Neutral | $87.00 |
| Apr 24, 2026 | Canaccord Genuity | Maintained | Hold | $85.00 |
| Apr 24, 2026 | Truist Securities | Maintained | Hold | $90.00 |
| Apr 24, 2026 | Evercore ISI Group | Maintained | Outperform | $93.00 |
| Apr 24, 2026 | BTIG | Maintained | Buy | $100.00 |

## Frequently Asked Questions

### What is the price target for EW stock?

The average 12-month analyst price target for Edwards Lifesciences (EW) is $104.57, with a high estimate of $110.00 and a low of $95.00, across 7 analysts.

### Is EW a buy, sell, or hold?

Analysts covering Edwards Lifesciences currently average a Buy rating: 24 buy, 7 hold and 0 sell, from 31 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for EW?

The average price target of $104.57 implies 18.70% upside from the last price of $88.10.

### What is the latest analyst rating on EW?

On Oct 7, 2026, Barclays initiated coverage of Edwards Lifesciences at Overweight with a price target of $110.00.

## Similar Stocks

- [AMN](https://www.lighthorse.io/tickers/amn) — AMN Healthcare Services Inc
- [HSIC](https://www.lighthorse.io/tickers/hsic) — Henry Schein, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).